Vol. 9 No. 4 (2008)

Vol. 9 No. 4 (2008)

Published: 2008-12-15

Growing impact of pharmacogenomic on drug development and personalized medicine

Mario Eandi

171-172
- PDF

Peg-interferon plus ribavirin in chronic hepatitis C: cost-efficacy and pharmacoutilization in clinical practice

Luisa Cavalletto, Elisabetta Bernardinello, Giulio Diodati, Enzo Raise, Angelo Gatta, Liliana Chemello

173-181
- PDF

Epidemiology and costs of HPV infection: review of the evidence

Francesco Bamfi, Alessia Marocco, Stefano Capri, Mario Giovanni Sideri

183-189
- PDF

Usefulness and limitation of DDD and PDD analyses. 12 months of solid oral antipsychotics prescribing data for the NHS-reimbursed treatment of schizophrenia in Italy

Lorenzo Pradelli

191-196
- PDF

Telbivudine (Sebivo) in patients with hepatitis B virus (HBV) chronic infection

Viola Sacchi

215-218
- PDF
Maraviroc (Celsentri) in HIV treatment

Viola Sacchi

219-222
- PDF